Displaying 1 - 1 of 1
| Active Ingredient | LOPINAVIR | RITONAVIR |
| Therapeutic Class | ANTIRETROVIRALS MISCELLANEOUS |
| Indications |
In combination with other antiretrovirals for the treatment of HIV- infection. |
| Caution | Headache, fatigue, diarrhoea and nausea. Increased blood lipids and infrequent cases of pancreatitis have been reported. As with other protease inhibitors, Lipodystrophy syndrome (i.e., increased More ... |
| Dose Range |
Adults and Pediatric12 years and older: Lopinavir 400/100 millgrams (mg) (lopinavir/ritonavir, respectively) twice daily taken with food. A dose increase to 533/133 mg twice daily is recommended whe lopinavir/ritonavir is taken concomitantly with e |
| Drug Interactions | |
| Pregnancy | Avoid oral solution due to high alcohol and propylene glycol content; use tablet More ... |
| Breast Feeding | The Centers for Disease Control and Prevention (CDC) and other experts recommend More ... |